"Designing Growth Strategies is in our DNA"

Neurovascular Devices Market Size, Share & Industry Analysis, By Device Type (Stenting Systems, Embolization Devices, Neurothrombectomy Devices, and Support Devices), By Application (Cerebral Aneurysms, Ischemic Stroke, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI101684

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 10.40% from 2026-2034

Unit

Value (USD billion)

Segmentation

By Device Type

  • Stenting Systems
  • Embolization Devices
  • Neurothrombectomy Devices
  • Support Devices

By Application

  • Cerebral Aneurysms
  • Ischemic Stroke
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America (By Device Type, By Application, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Device Type, By Application, By End-user, and By Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Device Type, By Application, By End-user, and By Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Device Type, By Application, By End-user, and By Country/Sub-region)
    • (Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Device Type, By Application, By End-user, and By Country/Sub-region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa
  • 2021-2034
  • 2025
  • 2021-2024
  • 140
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann